NVAX

Conviction 31HealthcareScan · Mon, Aug 10, 2026

Dragonfly doji

NVAX$7.89-0.82%

ResistanceSupportVol 14

Vol MA14 3.49M

May 11May 28Jun 16Jul 6Jul 23Aug 10

NOVAVAX INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.novavax.com ↗

Price7.89

Change-0.82%

Gap-1.01%

Rel volume1.82×

Avg volume3.27M

Avg $ vol25.5M

SMA 207.79

SMA 508.72

SMA 2008.44

Price vs 50-9.63%

Price vs 200-6.62%

MA stackmixed

50/200 cross—

Supertrenddown · 8.44

RSI (14)45

MACD hist0.08

MACD crossbull · 3d

Stoch %K / %D71 / 67

ADX (14)22

+DI / −DI18 / 20

RSI divergence—

MACD divergence—

ATR %+4.74%

ADR %4.04%

52w high11.19

52w low6.22

From 52w high-29.54%

Above 52w low+26.77%

New 52w highNo

SqueezeOff

Bollinger width17.86%

%B0.57

Donchian pos41.64%

Donchian high8.92

Donchian low7.15

AVWAP (52w high)9.25

vs AVWAP high-14.72%

AVWAP (52w low)8.83

vs AVWAP low-10.73%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d1.82×

Avg vol (14d)3.49M

Avg vol (20d)3.27M

Avg $ vol (20d)25.5M

Market cap1.3B

RS 3m (vs SPY)-19.57%

RS 6m (vs SPY)-13.10%

RS line new highNo

Trend template1/8

Technical rank22.7

1 week+6.41%

1 month-15.49%

3 months-22.01%

6 months-4.42%

1 year-10.19%

YTD+10.59%

P/E2.95

P/B-6.82

P/S1.16

P/FCF—

EPS2.58

Div yield—

ROE-230.88%

ROA46.08%

Debt/Eq-1.53

Current2.33

EV/EBITDA2.91

Gross margin—

Net margin39.19%

Rev growth64.69%

EPS growth334.83%

Price target13.25

Target upside68.04%

Analyst ratingBuy

Institutional83.96%

Ent. value1.4B

Revenue56.7M

Net income-53.39M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out164.44M

Employees749

ListedTue, Dec 5, 1995

Free float154.66M

Float %94.9%

Short interest43.82M

Days to cover11.4d

Short volume50.9%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.32 vs −$0.36

Last surprise+11.1% beat

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank22.7 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmDragonfly doji

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NVAX

All disclosures →

No recent disclosed trades by Congress in NVAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NVAX · 3 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Newton Charles W. Director · Common Stock · 2026-04-25	Exercise	9.52K	$0	2026-04-25	2026-04-28
Newton Charles W. Director · Restricted Stock Units · 2026-04-25	Exercise	9.52K	$0	2026-04-25	2026-04-28
Walker Robert Edward EVP, R&D · Restricted Stock Units · 2026-04-14	Grant	66K	$0	2026-04-14	2026-04-16
Walker Robert Edward EVP, R&D · Stock Option (Right to Buy) · 2026-04-14	Grant	99.5K	$0	2026-04-14	2026-04-16

SEC filings

EDGAR filings in NVAX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.